Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-costliest quintile among peers.
Brown Capital Mgmt Intl All Com Inv BCIIX
- NAV / 1-Day Return 16.46 / −0.30 %
- Total Assets 67.3 Mil
-
Adj. Expense Ratio
- Expense Ratio 1.250%
- Distribution Fee Level High
- Share Class Type No Load
- Category Foreign Large Growth
- Investment Style Large Growth
- Min. Initial Investment 5,000
- Status Open
- TTM Yield —
- Turnover 20%
USD | NAV as of Apr 24, 2024 | 1-Day Return as of Apr 24, 2024, 10:14 PM GMT+0
Morningstar’s Analysis BCIIX
Will BCIIX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 35.3
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Cochlear Ltd | 4.45 | 3.1 Mil | Healthcare |
Novo Nordisk A/S Class B | 4.30 | 3.0 Mil | Healthcare |
Icon PLC | 4.24 | 3.0 Mil | Healthcare |
Givaudan SA | 3.77 | 2.7 Mil | Basic Materials |
The Descartes Systems Group Inc | 3.31 | 2.3 Mil | Technology |
Chr. Hansen Holding A/S | 3.19 | 2.2 Mil | Basic Materials |
MercadoLibre Inc | 3.09 | 2.2 Mil | Consumer Cyclical |
Temenos AG | 3.09 | 2.2 Mil | Technology |
Dassault Systemes SE | 2.93 | 2.1 Mil | Technology |
Partners Group Holding AG | 2.92 | 2.1 Mil | Financial Services |